Background Whether thrombectomy alone is equally as effective as intravenous alteplase
plus thrombectomy remains controversial. We aimed to determine whether thrombectomy …

Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …

Background Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke have
been inconclusive. We investigated whether patients with cryptogenic stroke and …

Background Mechanical thrombectomy (MT) has become the cornerstone of acute ischemic
stroke management in patients with large vessel occlusion (LVO). Objective To assist …

Recent case-series of small size implied a pathophysiological association between coronavirus
disease 2019 (COVID-19) and severe large-vessel acute ischemic stroke. Given that …

Background and Purpose— The ABCD 2 score has been shown to predict the early risk of
stroke after transient ischemic attack (TIA). The additional predictive value of diffusion-…

Objective Emerging data indicate an increased risk of cerebrovascular events with severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and highlight the potential impact of …

Background and Purpose— After the demonstration of efficacy of bridging therapy, reliably
predicting early recanalization (ER; ≤3 hours after start of intravenous thrombolysis) would …

Early neurological deterioration (END) following ischaemic stroke is a serious event with
manageable causes in only a fraction of patients. The incidence, causes and predictors of END …

Importance Cerebral microbleeds (CMBs) have been established as an independent predictor
of cerebral bleeding. There are contradictory data regarding the potential association of …